Gastric Organoids for Disease Modelling (2014)
Source McCracken et al., 2014 · Cincinnati Children's Hospital Medical Center, Division of Developmental Biology · 10.1038/nature13863
Abstract
This protocol describes the directed differentiation of human pluripotent stem cells (ESCs and iPSCs) into three-dimensional human gastric organoids (hGOs) recapitulating antral development. hGOs contain surface mucous cells, antral gland cells, endocrine cells, and LGR5+ stem cells, and model physiological responses to Helicobacter pylori infection including CagA-dependent epithelial proliferation.
Protocol overview
16 steps across 5 phases
- a Culture pluripotent stem cells in feeder-free conditions
- a Plate pluripotent stem cells as single cells
- b Induce definitive endoderm
- a Establish foregut patterning conditions
- b Add retinoic acid on day 5
- c Harvest foregut spheroids
- a Continue retinoic acid treatment for antral specification
- b Transfer spheroids to three-dimensional Matrigel culture
- c Overlay with gut media containing EGF
- d Maintain organoid culture for maturation
- e Optional: Re-plate organoids at day 20
- f Optional: Reduce EGF for endocrine differentiation
- a Prepare H. pylori inoculum
- b Microinject H. pylori into organoid lumen
- c Culture infected organoids for 24 hours
- d Harvest infected organoids for analysis
Full SOP
Full SOPs need an account and a plan
Create an account, then get free Academic access (for verified academics) or choose a plan. Plans include step-by-step procedures, reagent concentrations, QC checklists and batch record templates.
Create an accountAlready registered? Log in
Attribution
This SOP was written by Organthis based on the published method in McCracken et al., 2014. Once the originating laboratory has confirmed it, the SOP is marked Verified.
Something wrong with this entry? Report an issue with this protocol